(Q39369228)

11 September 2017

Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer? (English)

1 reference

11 September 2017

1 reference

Ohori M

1

1 reference

11 September 2017

Dunn JK

series ordinal

2

1 reference

11 September 2017

Scardino PT

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

11 September 2017

1 reference

11 September 2017

46

1 reference

11 September 2017

666-671

1 reference

11 September 2017

5

1 reference

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

Prostate-specific antigen and premalignant change: implications for early detection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

Inter-relation between measurement of serum prostatic specific antigen and transrectal ultrasound in the diagnosis of benign prostatic hyperplasia and prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

Ultrasound guided transrectal core biopsies of the palpably abnormal prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980298-2

7 January 2021

10.1016/S0090-4295(99)80298-2

Identifiers

DOI

1 reference

11 September 2017

1 reference